1-8 of 8
Nabil K. Thalji
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Novel Rationally Developed Substrates for Factor IXa Demonstrate Active Site Differentiation between Factor IXa and Factor IXa-Padua

Lei Ke, Lindsey A. George, Nabil K. Thalji
Journal: Blood
Blood (2024) 144 (Supplement 1): 2581.
https://doi.org/10.1182/blood-2024-210733
Published: 2024
Journal Articles

Administration of Andexanet Alfa for Direct Factor Xa Inhibitor Reversal Precludes Therapeutic Heparinization for Cardiopulmonary Bypass

Nabil K. Thalji, MD PhD, Prakash A Patel, MD, Rodney M. Camire, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3640.
https://doi.org/10.1182/blood-2019-125955
Published: 2019
Journal Articles

Regulation of Factor VIII By Activated Protein C: Assessment In Vitro and In Vivo

Nicole A. Parsons, B.S., Michelle D. Ho, BS, Robert J. Davidson, BS, Nabil K. Thalji, PhDMD, Ben J. Samelson-Jones, MD PhD, Rodney M Camire, PhD, Lindsey A. George, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3650.
https://doi.org/10.1182/blood.V130.Suppl_1.3650.3650
Published: 2017
Journal Articles

RNA Aptamer Against FXa Synergizes with FXa Catalytic Site Inhibitors to Effectively and Reversibly Anticoagulate Blood in an Ex Vivo Oxygenator Circuit

Ruwan Gunaratne, MA, James Frederiksen, MD, Nabil K. Thalji, BS, Michelle D Ho, Gowthami M Arepally, MD, Rodney M. Camire, PhD, Bruce A. Sullenger, PhD
Journal: Blood
Blood (2016) 128 (22): 3823.
https://doi.org/10.1182/blood.V128.22.3823.3823
Published: 2016
Journal Articles

Prothrombin Membrane Binding and Gla-Dependent Function Are Not Required for Effective Hemostasis In Vivo

Lindsey A. Greene, MD, Nabil K. Thalji, BS, Harlan Bradford, BA, Sriram Krishnaswamy, PhD MD, Rodney M. Camire, PhD
Journal: Blood
Blood (2015) 126 (23): 124.
https://doi.org/10.1182/blood.V126.23.124.124
Published: 2015
Journal Articles

Zymogen-like FXa Variant As a Short-Acting Warfarin Reversal Agent: Pre-Clinical Evaluation and Mechanism of Action

Lindsey A. Greene, MD, Nabil K. Thalji, BS, Leslie J. Raffini, MD, Rodney M. Camire, PhD
Journal: Blood
Blood (2014) 124 (21): 4262.
https://doi.org/10.1182/blood.V124.21.4262.4262
Published: 2014
Journal Articles

Zymogen-like FXa Is a Potent Bypassing Agent for Reversal of Direct FXa Inhibitors in Vivo

Nabil K. Thalji, BS, Lacramioara Ivanciu, PhD, Reema Jasuja, Sunita Patel-Hett, PhD, Joachim Fruebis, PhD, Debra Pittman, Rodney M. Camire, PhD
Journal: Blood
Blood (2014) 124 (21): 582.
https://doi.org/10.1182/blood.V124.21.582.582
Published: 2014
Journal Articles

Zymogen-Like FXa Is An Effective Pro-Hemostatic To Reverse The Anticoagulant Effects Of Direct FXa Inhibitors

Nabil K Thalji, BS, Sunita Patel-Hett, PhD, Reema Jasuja, PhD, Joachim Fruebis, PhD, Debra Pittman, MS, Rodney M. Camire, PhD
Journal: Blood
Blood (2013) 122 (21): 2383.
https://doi.org/10.1182/blood.V122.21.2383.2383
Published: 2013